About (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one
(3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one (PubChem CID 96527278) has the molecular formula C18H14FN3O3
and a molecular weight of 339.33 g/mol. Its IUPAC name is (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one.
Analyze (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one?
The IUPAC name of (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one (CID 96527278) is (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one.
What is the SMILES notation for (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one?
The canonical SMILES for (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one is O=C1[C@H](Oc2ccc(-c3nnco3)cc2)CCN1c1ccccc1F.
What is the InChIKey of (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one?
The InChIKey is WOYGFRWSALCBCB-MRXNPFEDSA-N. The full InChI is InChI=1S/C18H14FN3O3/c19-14-3-1-2-4-15(14)22-10-9-16(18(22)23)25-13-7-5-12(6-8-13)17-21-20-11-24-17/h1-8,11,16H,9-10H2/t16-/m1/s1.
What are the key properties of (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one?
(3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one has a molecular weight of 339.33 g/mol, XLogP of 3.06, 4 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-1-(2-fluorophenyl)-3-[4-(1,3,4-oxadiazol-2-yl)phenoxy]pyrrolidin-2-one is sourced from PubChem (CID 96527278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).